search
Back to results

Effect of Heat Stress on Global LV Function in Anesthetized Humans

Primary Purpose

Hyperthermia, Cardiac Functional Disturbances During Surgery

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Transesophageal Echocardiography
Sponsored by
University of California, San Diego
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Hyperthermia

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • any patient presenting for hyperthermic intraperitoneal chemotherapy.

Exclusion Criteria:

  • Subjects less than 18 years old.
  • pregnant women
  • prisoners,
  • institutionalized individuals
  • Any patient with known contraindication to Transesophageal echocardiography.
  • Patients with known cardiac dysfunction prior to screening will be excluded.

Sites / Locations

  • University of California, San Diego

Outcomes

Primary Outcome Measures

Change in ejection fraction before and after hyperthermia

Secondary Outcome Measures

Transmitral inflow velocities before and after hyperthermia
Pulmonary venous inflow velocities before and during hyperthermia
Mitral annular tissue doppler velocities before and during hyperthermia

Full Information

First Posted
September 11, 2020
Last Updated
September 17, 2020
Sponsor
University of California, San Diego
search

1. Study Identification

Unique Protocol Identification Number
NCT04553900
Brief Title
Effect of Heat Stress on Global LV Function in Anesthetized Humans
Official Title
Effect of Heat Stress on Global LV Function in Anesthetized Humans
Study Type
Interventional

2. Study Status

Record Verification Date
September 2020
Overall Recruitment Status
Completed
Study Start Date
June 9, 2017 (Actual)
Primary Completion Date
December 6, 2019 (Actual)
Study Completion Date
December 6, 2019 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of California, San Diego

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Recent data suggests that increased temperature improves inotropic function during systole and may improve diastolic function in healthy humans at rest, despite a reduction in left ventricular volume at end diastole. The effect of heat stress has not been reported in patients receiving general anesthesia and the impact of general anesthesia on these findings is not known. Trans-esophageal echocardiography will be used to measure parameters important to both systolic and diastolic function at temperature intervals of 1°C in patients undergoing "Heated Intraoperative Peritoneal Chemotherapy" (HIPEC.) That general anesthesia will not alter the cardiovascular effects of increased temperature that has been reported in healthy, un-anesthetized humans is the hypothesis.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hyperthermia, Cardiac Functional Disturbances During Surgery

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
28 (Actual)

8. Arms, Groups, and Interventions

Intervention Type
Diagnostic Test
Intervention Name(s)
Transesophageal Echocardiography
Intervention Description
Placement of a transesophageal probe and performance of a diagnostic Transesophageal echocardiography examination.
Primary Outcome Measure Information:
Title
Change in ejection fraction before and after hyperthermia
Time Frame
Approximately 6 hours from prior to hyperthermia to during hyperthermia.
Secondary Outcome Measure Information:
Title
Transmitral inflow velocities before and after hyperthermia
Time Frame
Approximately 6 hours from prior to hyperthermia to during hyperthermia.
Title
Pulmonary venous inflow velocities before and during hyperthermia
Time Frame
Approximately 6 hours from prior to hyperthermia to during hyperthermia.
Title
Mitral annular tissue doppler velocities before and during hyperthermia
Time Frame
Approximately 6 hours from prior to hyperthermia to during hyperthermia.
Other Pre-specified Outcome Measures:
Title
heart rate before and during hyperthermia
Time Frame
Approximately 6 hours from prior to hyperthermia to during hyperthermia.
Title
mean arterial pressure before and during hyperthermia
Time Frame
Approximately 6 hours from prior to hyperthermia to during hyperthermia.

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: any patient presenting for hyperthermic intraperitoneal chemotherapy. Exclusion Criteria: Subjects less than 18 years old. pregnant women prisoners, institutionalized individuals Any patient with known contraindication to Transesophageal echocardiography. Patients with known cardiac dysfunction prior to screening will be excluded.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Edward O O'Brien, MD
Organizational Affiliation
University of California, San Diego
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of California, San Diego
City
La Jolla
State/Province
California
ZIP/Postal Code
92093
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Effect of Heat Stress on Global LV Function in Anesthetized Humans

We'll reach out to this number within 24 hrs